再发性分化甲状腺癌:当前的治疗选择
Andrés Coca-Pelaz1, Juan Pablo Rodrigo1, Jatin P Shah2
1Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, 33011 Oviedo, Spain.
Cancers
|June 22, 2023
概括
差异化甲状腺癌 (DTC) 复发,虽然不常见,但可以通过手术,放射性或先进的全身疗法 (如耐药病例的氨酸激酶抑制剂 (TKI)) 进行治疗.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 医疗治疗 医疗治疗
背景情况:
- 差异化甲状腺癌 (DTC) 一般具有良好的预后.
- 瘤复发发生在大约15%的病例中,受初始诊断和瘤生物学的影响.
- 复发可以在本地,区域或遥远地表现出来.
研究的目的:
- 为分化甲状腺癌复发提供当前和新兴治疗策略的全面概述.
- 讨论在手术或放射性等标准治疗方法不可行或不有效的情况下的管理选择.
主要方法:
- 关于差异化甲状腺癌复发管理的当前文献的综述.
- 分析已建立的治疗方法,包括手术,放射性治疗和外部光束辐射.
- 评估新型系统性治疗方法,特别是氨酸激酶抑制剂 (TKI).
主要成果:
- 局部和区域性复发通常可以通过手术和放射性治疗来控制.
- 孤立的远程转移,如骨转移,也可以对这些标准治疗做出反应.
- 系统性治疗,特别是TKI,在改善晚期或耐药病例的无进展生存率方面表现有前途.
结论:
- 对DTC复发的有效管理依赖于及时诊断和量身定制的治疗方法.
- 氨酸激酶抑制剂对具有放射性耐药或不可切除的DTC复发的患者来说是一个显著的进步.
- 对系统疗法的进一步研究对于优化复发性DTC的结果至关重要.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
201
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
201


